(Q38001360)

26 August 2017

Cardiovascular risk in double diabetes mellitus--when two worlds collide (English)

1 reference

26 August 2017

1 reference

Stephen J Cleland

1

1 reference

26 August 2017

10 April 2012

1 reference

Nature Reviews Endocrinology

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

8

1 reference

26 August 2017

476-485

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2012.47

26 August 2017

0 references

cites work

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Temporal patterns in overweight and obesity in Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The epidemiology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Pathogenesis and pathophysiology of the cardiometabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Adiposity and mortality in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Megatrials in type 2 diabetes. From excitement to frustration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Can clinical factors estimate insulin resistance in type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Natural course of insulin resistance in type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

In situ evidence that peripheral insulin resistance in adolescents with poorly controlled type 1 diabetes is associated with impaired suppression of lipolysis: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Hypertriglyceridaemia is associated with an increased likelihood of albuminuria in extreme duration (> 50 years) Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Lipid control in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Effects of a short-acting insulin analog (Insulin Lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Comparison of intraperitoneal and subcutaneous insulin administration on insulin sensitivity and serum lipids in type I diabetic patients on continuous ambulatory peritoneal dialysis treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Metabolic consequences of pancreatic systemic or portal venous drainage in simultaneous pancreas-kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Causes and metabolic consequences of Fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Impact of physical fitness and glycemic control on in vivo insulin action in adolescents with IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Effects of exercise training on insulin sensitivity in adolescents with type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Normalization of insulin sensitivity in type I diabetic subjects by physical training during insulin pump therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Insulin receptor function and glycogen synthase activity in skeletal muscle biopsies from patients with insulin-dependent diabetes mellitus: effects of physical training

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The use of metformin in type 1 diabetes: a systematic review of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Addressing insulin resistance in Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The effect of rosiglitazone on overweight subjects with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

A low-fat diet improves peripheral insulin sensitivity in patients with Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Endothelial dysfunction precedes development of microalbuminuria in IDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Images in clinical medicine. Paget's disease of the mandible

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Epidemiological evidence for "double diabetes"

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

31 March 2020

How to survive diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Impact of physical activity on cardiovascular risk factors in IDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Dimethyldiguanide in the treatment of diabetic children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Failure of the biguanides to improve the control of unstable diabetes treated with insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.47

Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes

31 March 2020

1 reference

12 December 2020

Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.

1 reference

12 December 2020

Expression of GLUT1 and GLUT4 glucose transporters in skeletal muscle of humans with insulin-dependent diabetes mellitus: regulatory effects of metabolic factors

1 reference

12 December 2020

Insulin resistance in type I diabetes mellitus: a major role for reduced glucose extraction

1 reference

12 December 2020

Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2012.47

1 reference

26 August 2017

1 reference

PubMed ID

22488644